Has Peter Belin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,205 in general payments to Peter Belin, MD across 11 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Peter Belin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Peter Belin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Peter Belin, MD

Ophthalmology · Edina, MNNPI 1275929259

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,345 of the $9,205 with a category attached, or 68.9%. Genentech USA, Inc. accounts for 79.6% of it on its own, with 2 other manufacturers making up the rest. 2024 is the largest year on record at $7,323, 4.6 times the $1,602 reported in 2019. Among ophthalmology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,205in general payments, 2019–2025

Across 11 payments — averaging $836.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Genentech USA, Inc.$7K
Alcon$2K
Dutch Ophthalmic, USA$281

What the payments were for

Consulting fees$6,34569%
Travel & lodging$1,57017%
Food & beverage$1,29014%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Genentech USA, Inc.	4	$7,323
Alcon	5	$1,602
Dutch Ophthalmic, USA	2	$281

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,205 in reported general payments places this provider in the 90th percentile of 330 ophthalmology providers in Minnesota.

See all ophthalmology providers in Minnesota →

Medicare billing

Part B allowed, 2024

$3,170,784

Medicare patients

839

Services billed

30,043

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Bromfenac Sodium	30	$6,694
Prednisolone Acetate	130	$6,585
Ketorolac Tromethamine	209	$4,435
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	121	$1,458
Brimonidine Tartrate	16	$1,345
Atropine Sulfate	28	$1,196
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	31	$864
Timolol Maleate	34	$342

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Edina

Adam MossEdina$9K
Jeffrey StephensEdina$7K
Tsun Kang ChiangEdina$5K
Ryan JohnsonEdina$4K
Jeffrey SandersonEdina$4K
Rhondi MeiusiEdina$3K
Christopher StefonowiczEdina$3K
Jess BoysenEdina$3K
Scott SchaeferEdina$3K
Michael ElliottEdina$3K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →